3-(2-amino-5-methoxyphenyl)acrylic acid methyl ester | 125810-72-2

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: 3-(2-amino-5-methoxyphenyl)acrylic acid methyl ester
• 英文别名: methyl 3-(2-amino-5-methoxyphenyl)acrylate；Methyl 3-(2-amino-5-methoxyphenyl)prop-2-enoate
• CAS: 125810-72-2
• 化学式: C₁₁H₁₃NO₃
• 分子量: 207.229
• InChiKey: DDZBRWSBJMCIDH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  61.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  3-(2-amino-5-methoxyphenyl)acrylic acid methyl ester 在 盐酸 、 sodium nitrite 、 sodium azide 作用下， 以 乙醇 、 水 为溶剂， 反应 3.83h， 生成
  参考文献：
  名称：

  [Fe（F（20）TPP）Cl]催化分子内CN键的形成，以芳基叠氮化物为氮源进行生物碱合成。

  摘要：

  通过使用芳基叠氮化物作为氮源的[Fe（F（20）TPP）Cl]催化的分子内CN键形成，已成功完成了包括吲哚，二氢吲哚，四氢喹啉，二氢喹唑啉酮和喹唑啉酮在内的生物碱的合成。

  DOI：

  10.1039/c0cc01825b
• 作为产物：
  描述：

  5-甲氧基-2-硝基苯甲醛 在 铁粉 、 氯化铵 作用下， 以 乙醇 、 水 、 甲苯 为溶剂， 反应 5.0h， 生成 3-(2-amino-5-methoxyphenyl)acrylic acid methyl ester
  参考文献：
  名称：

  Novel acid-type cyclooxygenase-2 inhibitors: Design, synthesis, and structure–activity relationship for anti-inflammatory drug

  摘要：

  Cyclooxygenase (COX) is a key rate-limiting enzyme for prostaglandin (PG) production cascades in the human body. The mechanisms of both the anti-inflammation effects and the side-effects of traditional COX inhibitors are associated with the existence of two COX isoforms. Thus while COX-1 is predominantly expressed ubiquitously and constitutively, and it serves a housekeeping role in processes such as gastrointestinal (GI) mucosa protection, COX-2 is absent or exhibits a low level of expression in most tissues, and is highly upregulated in response to endotoxin, virus, inflammatory or tissue-injury stimuli/signals, and tumour promoter in the various types of organs, tissues, and cells. Furthermore, COX-2 contribution to PGE(2) and PGI(2) production evokes and sustains systemic or peripheral inflammatory disease, but it is not involved in the COX-1-mediated GI tract events. Also, hypersensitivity of aspirin owing to its inhibitory action against COX-1 is a significant concern clinically. Consequently, highly selective COX-2 inhibitors have been needed for the treatment of inflammatory- and inflammation related-diseases that include pyrexia, inflammation, pain, rheumatoid arthritis, osteoarthritis, and cancers. In this study, a series of novel [2-{[(4-substituted or 4,5-disubstituted)-pyridin-2-yl]carbonyl}-(5- or 6-substituted or 5,6-disubstituted)-1H-indol-3-yl]acetic acid analogues was designed, synthesized, and evaluated to identify potent and selective COX-2 inhibitors as potential agents against inflammatory diseases. As significant findings, the present study clarified unique structure activity relationship of the analogues toward potent and selective COX-2 inhibition in vitro, and identified 2-{6-fluoro-2-[4-methyl-2-pridinyl)carbonyl]-1H-indol-3-yl}acetic acid as a potent and selective COX-2 inhibitor in vitro that demonstrated orally potent anti-inflammation efficacy against carrageenan-induced oedema formation in the foot of SPF/VAF male SD rats as a peripheral inflammation model in vivo. (C) 2012 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2012.01.053

文献信息

• Photoredox Catalysis toward 2-Sulfenylindole Synthesis through a Radical Cascade Process
  作者：Marilia S. Santos、Hugo L. I. Betim、Camila M. Kisukuri、Jose Antonio Campos Delgado、Arlene G. Corrêa、Márcio W. Paixão

  DOI：10.1021/acs.orglett.0c01297

  日期：2020.6.5

  A radical cascade process initiated through visible-light induced thiyl radical coupling with ortho-substituted arylisocianides followed by an intramolecular cyclization and subsequent aromatization to access 2-sulfenylindoles is described. The key thiyl radicals are promptly generated via a hydrogen atom transfer event. The redox-neutral protocol features broad substrate scope, excellent functional

  描述了一种自由基级联过程，该过程通过可见光诱导的噻吩自由基与邻位取代的芳基抗微生物剂偶联，随后的分子内环化和随后的芳构化来获得2-亚硫基吲哚而引发。关键的噻吩基经由氢原子转移事件迅速产生。氧化还原中性方案具有广泛的底物范围，出色的官能团耐受性和温和的反应条件。此外，通过流程增强，连续流变型的实现允许在较短的停留时间内实现平稳的可伸缩性。
• Synthesis of 2-Boryl- and Silylindoles by Copper-Catalyzed Borylative and Silylative Cyclization of 2-Alkenylaryl Isocyanides
  作者：Mamoru Tobisu、Hirokazu Fujihara、Keika Koh、Naoto Chatani

  DOI：10.1021/jo101024f

  日期：2010.7.16

  2-borylindoles via the copper(I)-catalyzed borylative cyclization of 2-alkenylphenyl isocyanides using diboronate. The reaction proceeds at room temperature under neutral conditions and exhibits high tolerance to functional groups, such as Br, CO2R, COR, CONMe2, and CN. The 2-borylindoles synthesized in the present study can be elaborated into an array of indole-based derivatives, for example, through the

  我们已经开发了一种通过使用二硼酸酯经铜（I）催化的2-烯基苯基异氰酸酯的硼化环化来合成2-硼吲哚的方法。反应在室温，中性条件下进行，并且对Br，CO 2 R，COR，CONMe 2等官能团具有较高的耐受性和CN。在本研究中合成的2-硼基吲哚可以通过例如Suzuki-Miyaura反应合成为一系列基于吲哚的衍生物。该方法的实用性在激酶抑制剂paullone的快速合成中得到了证明。通过分别使用氢硼酸酯（或氢硅烷）和甲硅烷基硼酸酯，可以将反应扩展到2-氢化吲哚和2-甲硅烷基吲哚的合成。在这些铜催化的条件下，也可以通过使用1,2-异氰基苯作为底物来构建喹喔啉环系统。
• Copper-Catalyzed Dihydroquinolinone Synthesis from Isocyanides and <i>O</i>-Benzoyl Hydroxylamines
  作者：Zhen Yang、Kun Jiang、Ying-Chun Chen、Ye Wei

  DOI：10.1021/acs.joc.9b00262

  日期：2019.3.15

  A copper-catalyzed protocol has been realized for the rapid assembly of dihydroquinolinones from readily accessible isocyanides and O-benzoyl hydroxylamines. The reactions (10 mol % of CuOAc, 10 mol % of dppe, 3 equiv of PhONa, 30 °C) deliver various structurally interesting dihydroquinolinones in moderate to good yields (up to 76%). The reactions may proceed in a cascade manner involving isocyanide

  已经实现了铜催化的方案，用于从容易获得的异氰酸酯和O-苯甲酰基羟胺快速组装二氢喹啉酮。反应（10 mol％的CuOAc，10 mol％的dppe，3当量的PhONa，30°C）以中等至良好的收率（高达76％）提供了各种结构有趣的二氢喹啉酮。反应可能以级联方式进行，包括将异氰酸酯插入N–O键，Mumm型重排和分子内亲核取代。
• Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents and as COX-2 inhibitors
  申请人：PFIZER INC.

  公开号：EP1065204A1

  公开（公告）日：2001-01-03

  This invention provides a compound of the following formula: or the pharmaceutically acceptable salts thereof wherein A is C 1-6alkylene or -NR1-; Z is C(=L)R2, or SO2R3; U is CH or N; W and Y are independently selected from - CH2-, O, S and -N-R1; m is 1, 2 or 3; q and r are independently 0, 1 or 2; X is independently selected from halogen, C 1-4alkyl, halo-substituted C 1-4 alkyl, hydroxy, C 1-4alkoxy, halo-substituted C 1-4 alkoxy or the like; n is 1 or 2; L is oxygen or sulfur; R1 is hydrogen or C 1-4 alkyl; R2 is hydroxy, C1-6alkyl, halo-substituted C 1-6 alkyl, C 1-6 alkoxy, halo-substitutued C 1-6 alkoxy, C 3-7 cycloalkoxy, C 1-4 alkyl(C 3-7 cycloalkoxy), -NR4R5 or the like; R3 is C 1-6 alkyl or halo-substituted C 1-6 alkyl; and R4 and R5 are independently selected from hydrogen, C 1-6alkyl and halo-substituted C 1-6alkyl. This invention also provides a pharmaceutical composition useful for the treatment of a medical condition in which prostaglandins are implicated as pathogens.

  本发明提供了下式化合物： 或其药学上可接受的盐 其中A为C 1-6烷基或-NR1-；Z为C(＝L)R2或SO2R3；U为CH或N；W和Y独立地选自-CH2-、O、S和-N-R1；m为1、2或3；q和r独立地为0、1或2；X独立地选自卤素、C 1-4烷基、卤代C 1-4烷基、羟基、C 1-4烷氧基、卤代C 1-4烷氧基或类似物；n 是 1 或 2；L 是氧或硫；R1 是氢或 C 1-4 烷基；R2 是羟基、C1-6 烷基、卤代 C 1-6 烷基、C 1-6 烷氧基、卤代 C 1-6 烷氧基、C 3-7 环烷氧基、C 1-4 烷基（C 3-7 环烷氧基）、-NR4R5 或类似物；R3 是 C 1-6 烷基或卤代 C 1-6 烷基；以及 R4 和 R5 独立选自氢、C 1-6 烷基和卤代 C 1-6 烷基。 本发明还提供了一种药物组合物，可用于治疗前列腺素被认为是病原体的病症。
• 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS
  申请人：PFIZER INC.

  公开号：EP1045833B1

  公开（公告）日：2005-11-02